Element Capital Management’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNTX
PL
HBWM
JA
Element Capital Management's RNTX Position: Q4 2018 in Review
Element Capital Management sold out of Rein Therapeutics (RNTX) in Q4 2018, closing a stake of 697 shares — an estimated $38K sold.
Element Capital Management first reported a position in RNTX in Q2 2018 and held it in 2 quarters. The position peaked at $158K in Q2 2018. 23 funds tracked by Wall St. Rank hold RNTX as of Q4 2018.
- Element Capital Management reported no remaining Rein Therapeutics position as of Q4 2018 after selling out during the quarter.
- Element Capital Management sold 697 Rein Therapeutics shares in Q4 2018, an estimated $38K.
- Element Capital Management first reported a position in Rein Therapeutics in Q2 2018 and held it in 2 quarters.
- Element Capital Management's Rein Therapeutics position peaked at $158K in Q2 2018.
- 23 funds tracked by Wall St. Rank held Rein Therapeutics as of Q4 2018.
Based on Element Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.